MYGN
Myriad Genetics Inc.
$8.04
+$0.09(+1.13%)
59
Overall
60
Value
75
Tech
42
Quality
Market Cap
$756.45M
Volume
903.97K
52W Range
$3.76 - $19.60
Target Price
$7.68
EPS Estimates Overview
| Current Quarter | $-0.11 | Next Quarter | $-0.09 |
| Current Year | $-0.4 | Next Year | $-0.3 |
| QoQ Growth | +18.2% | YoY Growth | +25.0% |
| 3Y EPS CAGR | -59.1% | Target Price | $7.68 |
| Consensus | Buy | Upside | -4.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MYGN | $8.04 | +1.1% | 903.97K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |